These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6174449)

  • 21. Isoenzyme analysis of typhoid-Shigella and Escherichia-Shigella hybrid vaccines and their parental strains.
    Schultz C
    J Clin Microbiol; 1989 Dec; 27(12):2838-41. PubMed ID: 2687324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
    Viret JF; Cryz SJ; Lang AB; Favre D
    Mol Microbiol; 1993 Jan; 7(2):239-52. PubMed ID: 7680409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
    Salerno-Goncalves R; Pasetti MF; Sztein MB
    J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen.
    Attridge SR; Dearlove C; Beyer L; van den Bosch L; Howles A; Hackett J; Morona R; LaBrooy J; Rowley D
    Infect Immun; 1991 Jul; 59(7):2279-84. PubMed ID: 1711014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen.
    Kopecko DJ; Washington O; Formal SB
    Infect Immun; 1980 Jul; 29(1):207-14. PubMed ID: 6249756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210.
    Attridge SR; Daniels D; Morona JK; Morona R
    Microb Pathog; 1990 Mar; 8(3):177-88. PubMed ID: 1696342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmonella-based vaccines.
    Hackett J
    Vaccine; 1990 Feb; 8(1):5-11. PubMed ID: 2180232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli].
    Teng J; Rui X; Zhang Y; Zhang Z; Su G
    Wei Sheng Wu Xue Bao; 1999 Dec; 39(6):533-8. PubMed ID: 12555559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.
    Clements JD; El-Morshidy S
    Infect Immun; 1984 Nov; 46(2):564-9. PubMed ID: 6389350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
    Tacket CO; Forrest B; Morona R; Attridge SR; LaBrooy J; Tall BD; Reymann M; Rowley D; Levine MM
    Infect Immun; 1990 Jun; 58(6):1620-7. PubMed ID: 1692807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.
    Gilman RH; Hornick RB; Woodard WE; DuPont HL; Snyder MJ; Levine MM; Libonati JP
    J Infect Dis; 1977 Dec; 136(6):717-23. PubMed ID: 925379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.
    Hone DM; Attridge SR; Forrest B; Morona R; Daniels D; LaBrooy JT; Bartholomeusz RC; Shearman DJ; Hackett J
    Infect Immun; 1988 May; 56(5):1326-33. PubMed ID: 3356467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
    Wahid R; Fresnay S; Levine MM; Sztein MB
    Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY; Tsang RS
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.